Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02180178

Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry

Primary goal of the registry is to collect prospective data on patients undergoing coronary angiography in Mainz. Following amendment of the procol, this study will also include patients who received an Aborb bioresorbable scaffold for the therapy of de novo stenoses.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Coronary Artery Disease Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Coronary Disease Heart Diseases Microvascular Dysfunction Myocardial Ischemia Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

University Medical Center Mainz - 2 Medizinische Klinik

Mainz, 55131, Germany

Location status: Recruiting

Location contact

Boris Schnorbus, Dr med

SUB_INVESTIGATOR

Tommaso Gori

PRINCIPAL_INVESTIGATOR

Tommaso Gori, PhD Dott Med Chir

CONTACT

[email protected]

+496131172829

About this study

Patients included in the registry will be contacted by telephone at 3,6,9, 12 months and 2, 5, 10 years after the procedure. In case coronary slow flow is shown at the index procedure, 39ml of blood will be drawn for further studies.

According to the regulations of the Province Rheinland-Pfalz, national law, and with the approval of the Ethic commission of the Landesärztekammer Rheinland Pfalz, patients (n=1000) will also be retrospectively entered in the database in an anonymous way. For these patients, no specific study procedure is foreseen and the MICAT database will be only used as a platform (database of anonymous data collected during routine clinical practice).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • clinical indication to coronary angiography

Exclusion criteria

  • none

Treatment and study plan

observational only- no intervention

Other

Primary outcomes

  1. Major adverse cardiovascular events

    Time frame: baseline to 10 years

    Incidence of major adverse events (death, death of cardiac cause, TLR - target lesion revascularization, MI)

Secondary outcomes

  1. Individual endpoints

    Time frame: baseline to 10 years

    Each individual endpoint of the MACE previously described

  2. Other cardiovascular endpoints

    Time frame: baseline to 10 years

    TVR - target vessel revascularization, re-hospitalization, change in medications.

Study contacts

Contact information is provided by the study sponsor or research team.

Tommaso Gori, PhD, Dott medicina e Chirurgia

CONTACT

[email protected]

+49 6131 172829

Sponsors and collaborators

Lead sponsor

Johannes Gutenberg University Mainz

Other

Registry information

Official study title

Mainzer IntraCoronAry daTabase (MICAT). Das Coronary Slow Flow- Syndrom Und Koronare Mikrozirkulationsstörungen- Register.

Acronym: MICAT

Important dates

Study start
2013
Primary completion
2028
Study completion
2028
First posted
Jul 2, 2014
Registry last updated
Oct 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.